Equasens (EQS) | Stock Overview & Key Data
Equasens Performance Comparison
Stock Range
Today's Range
52 Week Range
All-Time High: €124.20 on January 18, 2021
Explore how other French stocks compare to their 52-week ranges: View FR Market 52-Week Insights
Dividend Information
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Equasens
EQS
|
589.23M Mid-cap | -4.49% | 0.54% | 4.49% | -15.93% | -17.06% | -21.00% | -54.76% | -60.04% | 56.44% | 253.82% | 253.82% |
|
Cegedim S.A
CGM
|
188.10M Mid-cap | 2.17% | 2.91% | -0.26% | -0.26% | -0.26% | 4.52% | 4.52% | 4.52% | 4.52% | 4.52% | 4.52% |
|
Smaio S.A
ALSMA
|
47.02M Small-cap | -13.33% | -3.58% | 4.00% | 14.24% | 22.60% | 107.94% | 167.35% | 46.37% | 46.37% | 46.37% | 46.37% |
|
Abl Diagnostics
ABLD
|
44.38M Small-cap | -2.16% | -17.58% | -19.05% | -12.26% | -29.17% | -50.09% | -58.15% | 1.87% | -3.20% | 8.80% | 8.80% |
|
Intrasense S.A
ALINS
|
11.80M Small-cap | 4.35% | 0.00% | 20.00% | -7.69% | 4.35% | -25.81% | -46.51% | -70.51% | -72.29% | -95.93% | -95.93% |
|
Media Lab S.p.A
MLLAB
|
8.06M Small-cap | -5.33% | 0.00% | 10.34% | 5.26% | -10.61% | 60.00% | 153.97% | 84.97% | -6.71% | -6.71% | -6.71% |
Calculate Your Equasens Investment Returns
Long-Term Investment Performance Analysis
Equasens stock price in Jul 2016 was €26.60, A €1,000.00 lump sum investment in Equasens made 9 years ago would be worth approximately €1,398.50 today, representing a positive return of 39.85%. This translates to an annualized return (CAGR) of 3.44%.
9 Years 10 Months Investment Scenario (Jul 2016 - Jun 2026)
Investment Breakdown
Value Comparison
Disclaimer: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing. Past performance does not guarantee future results.
Frequently Asked Questions
- What is EQS's 52-week high and low?
- In the last 52 weeks, Equasens reached a high of €53.70 (on August 6, 2025) and a low of €33.70 (on N/A).
- What is the market cap and P/E ratio for EQS?
- Curious about Equasens's size and valuation? Its market capitalization stands at 589.23M. When it comes to valuation, the P/E ratio (trailing twelve months) is N/A, and the forward P/E (looking ahead) is N/A.
- Does EQS pay dividends? If so, what's the yield?
- Yes, Equasens is a dividend-paying stock. Investors have recently enjoyed a trailing annual dividend yield of 2.53%, and the company has paid an average of €1.22 per share annually over the past 3 years.
- Who are Equasens's main competitors or similar companies to consider before investing?
When looking at Equasens, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Cegedim S.A
CGM188.10M Healthcare Health Information Services 4.52% 4.52% Smaio S.A
ALSMA47.02M Healthcare Health Information Services 107.94% 167.35% Abl Diagnostics
ABLD44.38M Healthcare Health Information Services -50.09% -58.15% Intrasense S.A
ALINS11.80M Healthcare Health Information Services -25.81% -46.51% Media Lab S.p.A
MLLAB8.06M Healthcare Health Information Services 60.00% 153.97% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Equasens? (e.g., ROE, Debt/Equity)
- To get a sense of Equasens's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is N/A, the Debt to Equity ratio from the most recent quarter is N/A, and its Gross Profit Margin stands at N/A.
- What is the recent revenue and earnings growth for EQS?
- Looking at Equasens's growth, its revenue over the trailing twelve months (TTM) was N/A. Compared to the same quarter last year (YoY), quarterly revenue grew by N/A, and quarterly earnings saw a YoY growth of N/A.
- How much of EQS stock is held by insiders and institutions?
- Wondering who owns Equasens stock? Company insiders (like executives and directors) hold about N/A of the shares, while institutional investors (such as mutual funds and pension funds) own approximately N/A.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.